In the last few decades immunotherapy has become an important part of treating some types of cancer. Newer types of immune treatments are now being studied, and they’ll impact how we treat cancer in the future. - ACS
The signaling pathways controlling cell growth and differentiation are almost invariably altered in cancer, and deciphering these interconnected signaling pathways is leading to the development of monoclonal antibody cancer drugs. To design a monoclonal antibody, researchers first have to identify the right target antigen to attack…
Monitoring autoantibody levels and the response to antigens will help us further understand anti-tumor immunity and may also help us to monitor cancer progress and cancer vaccine efficacy in the future….
Cancer Research Services
LC Sciences offers a range of services applicable to clinical cancer research . Contact us to find out more.